Pembrolizumab tunes up chemotherapy in cervical cancer
- PMID: 34616034
- DOI: 10.1038/s41571-021-00570-5
Pembrolizumab tunes up chemotherapy in cervical cancer
Comment on
-
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.N Engl J Med. 2021 Nov 11;385(20):1856-1867. doi: 10.1056/NEJMoa2112435. Epub 2021 Sep 18. N Engl J Med. 2021. PMID: 34534429 Clinical Trial.
References
Original article
-
- Colombo, N. et al. Pembrolizumab for persistent, recurrent, or metastatic cervical cancer. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2112435 (2021) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical